Apollo Endosurgery Revenue and Competitors
Estimated Revenue & Valuation
- Apollo Endosurgery's estimated annual revenue is currently $128.3M per year.
- Apollo Endosurgery's estimated revenue per employee is $351,400
- Apollo Endosurgery's total funding is $433.5M.
Employee Data
- Apollo Endosurgery has 365 Employees.
- Apollo Endosurgery grew their employee count by 25% last year.
Apollo Endosurgery's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Global Human Resources | Reveal Email/Phone |
2 | VP US Sales | Reveal Email/Phone |
3 | VP, Legal and Compliance | Reveal Email/Phone |
4 | VP, Global Clinical & Medical Affairs | Reveal Email/Phone |
5 | EVP, Operations | Reveal Email/Phone |
6 | VP, Marketing and Medical Education | Reveal Email/Phone |
7 | Director, Clinical Affairs | Reveal Email/Phone |
8 | Senior Director Medical Education | Reveal Email/Phone |
9 | Senior Director Professional Education | Reveal Email/Phone |
10 | Regional Business Director | Reveal Email/Phone |
Apollo Endosurgery Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $18.6M | 74 | 21% | N/A | N/A |
#2 | $37.7M | 150 | -7% | N/A | N/A |
#3 | $1.4M | 11 | -31% | $5.1M | N/A |
#4 | $49.7M | 198 | 14% | N/A | N/A |
#5 | $1.3M | 10 | 0% | $6.3M | N/A |
#6 | $60.7M | 242 | N/A | N/A | N/A |
#7 | $28.1M | 112 | 8% | N/A | N/A |
#8 | $5.5M | 22 | -19% | N/A | N/A |
#9 | $3M | 12 | -20% | N/A | N/A |
#10 | $10.3M | 41 | N/A | N/A | N/A |
What Is Apollo Endosurgery?
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal conditions. Apollo?s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo?s products are offered in over 70 countries today and include the OverStitch? Endoscopic Suturing System, the ORBERA® Intragastric Balloon, and the LAP-BAND® Adjustable Gastric Banding System. Learn more about our products at: OverStitch - www.overstitch.com ORBERA Gastric Balloon - www.orbera.com LAP-BAND - www.lap-band.com
keywords:N/A
$433.5M
Total Funding
365
Number of Employees
$128.3M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Apollo Endosurgery News
Get Apollo Endosurgery alerts: 91.5% of Apollo Endosurgery shares are held by institutional investors. Comparatively, 14.8% of INVO Bioscience...
Apollo Endosurgery, Inc. (NASDAQ:APEN) Given Consensus Recommendation of Buy by Analysts. Posted by admin on Apr 19th, 2022.
Ms. Bankes brings 30 years of experience in the medical device and pharmaceutical industries to her role on the Apollo Endosurgery Board of...
Apollo Endosurgery Announces Positive MERIT-Trial Outcomes October 22, 2021 Trial Results Demonstrate ESG Procedure Offers Significant and Durable Weight Loss, with Improvements in Obesity-Related Health Conditions MERIT-Trial met its primary endpoints for safety and efficacy, with patients un ...
Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares October 15, 2021 AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointest ...
Other Companies in Austin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $96.1M | 366 | 22% | N/A |
#2 | $66.7M | 368 | 5% | N/A |
#3 | $65.6M | 369 | -8% | $40M |
#4 | $114.2M | 370 | 2% | $15M |
#5 | $80M | 372 | 11% | N/A |